These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19390347)
1. The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) rat. Dixon RA; Davidson SM; Wynne AM; Yellon DM; Smith CC J Cardiovasc Pharmacol; 2009 Apr; 53(4):311-7. PubMed ID: 19390347 [TBL] [Abstract][Full Text] [Related]
2. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254 [TBL] [Abstract][Full Text] [Related]
3. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Smith CC; Dixon RA; Wynne AM; Theodorou L; Ong SG; Subrayan S; Davidson SM; Hausenloy DJ; Yellon DM Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1265-70. PubMed ID: 20656889 [TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553 [TBL] [Abstract][Full Text] [Related]
8. Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury. Smith CC; Lim SY; Wynne AM; Sivaraman V; Davidson SM; Mocanu MM; Hausenloy DJ; Yellon DM J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):63-71. PubMed ID: 21183727 [TBL] [Abstract][Full Text] [Related]
9. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084 [TBL] [Abstract][Full Text] [Related]
10. Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy. Li J; Umar S; Iorga A; Youn JY; Wang Y; Regitz-Zagrosek V; Cai H; Eghbali M Basic Res Cardiol; 2012 Jul; 107(4):271. PubMed ID: 22648276 [TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance. Yu P; Zhang J; Yu S; Luo Z; Hua F; Yuan L; Zhou Z; Liu Q; Du X; Chen S; Zhang L; Xu G PLoS One; 2015; 10(8):e0134666. PubMed ID: 26263161 [TBL] [Abstract][Full Text] [Related]
12. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart. Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381 [TBL] [Abstract][Full Text] [Related]
16. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182 [TBL] [Abstract][Full Text] [Related]
17. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts. Balakumar P; Singh H; Reddy K; Anand-Srivastava MB J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176 [TBL] [Abstract][Full Text] [Related]
18. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. Pan H; Li D; Fang F; Chen D; Qi L; Zhang R; Xu T; Sun H J Cardiovasc Pharmacol; 2011 Nov; 58(5):535-42. PubMed ID: 21795988 [TBL] [Abstract][Full Text] [Related]
19. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503 [TBL] [Abstract][Full Text] [Related]
20. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]